Vital Nutrients® Sleep + Recover: The Pharmacist's Guide to Sleep Optimization & Overnight Recovery

Dai Tran, PharmD, MBA, B.S.

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist

Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience

The Clinical Question

Vital Nutrients® Sleep + Recover is a seven-ingredient botanical and nutritional formula designed to support sleep onset, sleep quality, and overnight recovery. Its ingredients include Melatonin, L-Theanine, Ashwagandha, Saffron Extract, 5-HTP, Passion Flower, and Lemon Balm — each with proposed mechanisms related to sleep, relaxation, or serotonin-melatonin signaling.

This article reviews what human clinical research actually supports for each ingredient, in order of current evidence strength. Ingredient-level evidence does not establish the efficacy or safety of the finished combination product.

Supplement Facts (Per 1-Capsule Serving)

Serving size: 1 vegetarian capsule | Servings per container: 30 | Suggested use: Take 1 capsule 30–60 minutes before bedtime as directed by your healthcare professional. Do not drive or operate heavy machinery after taking.

* Daily Value not established. Other ingredients: Vegetarian Capsule (Cellulose), Ascorbyl Palmitate, Cellulose, Silica. Vegan. Gluten-free. Third-party tested. cGMP-certified.

What the Evidence Does — and Does Not — Establish

• Established: Melatonin has the strongest human sleep evidence in this formula, with meta-analyses confirming modest improvements in sleep onset latency, total sleep time, and overall sleep quality in primary sleep disorders.
• Preliminary: L-Theanine, Ashwagandha, Saffron, and 5-HTP each have small human RCTs with positive sleep-related signals. Passion Flower has one small short-duration human trial using a tea preparation. Lemon Balm’s most cited sleep study was open-label and uncontrolled.
• Not established: That the combination of these seven ingredients produces additive or superior sleep benefit compared to individual ingredients or placebo. The proposed multi-pathway mechanisms are based on preclinical pharmacology and the individual-ingredient literature; combined human RCT evidence for this specific formula is not available.

Sleep and Why It Matters

Sleep is a period of active biological repair: the brain clears metabolic waste via the glymphatic system, consolidates memory, and restores neurotransmitter balance. The body simultaneously repairs muscle tissue, secretes growth hormone, regulates immune function, and rebalances hormonal systems. Chronic sleep insufficiency is associated with increased cardiovascular, metabolic, and cognitive risk. Supplement support for sleep is an active research area; evidence quality varies considerably by ingredient and outcome studied.

Ingredient-by-Ingredient Evidence Review

Presented in order of current human clinical evidence strength for sleep outcomes.

1. Melatonin — 2 mg [Strongest evidence]

Melatonin is the primary circadian rhythm hormone, synthesized by the pineal gland in response to darkness. It is the most extensively studied ingredient in this formula for sleep outcomes.

• A meta-analysis of 19 randomized placebo-controlled trials (Ferracioli-Oda et al., PMID: 23691095; 1,683 participants) evaluating melatonin in primary sleep disorders found melatonin produced modest improvements in sleep-onset latency, total sleep time, and overall sleep quality. Effects were statistically significant but generally modest, and outcomes varied across populations and sleep disorders.
• Separate evidence supports melatonin for jet lag and delayed sleep phase disorder; the Ferracioli-Oda meta-analysis specifically addressed primary sleep disorders.
• The 2 mg dose in this formula falls within the range used in many human sleep studies. Optimal dose and timing vary by indication, age, formulation, and desired circadian effect; higher doses are not necessarily more effective. May cause morning drowsiness in sensitive individuals.

2. L-Theanine — 150 mg [Modest human RCT evidence]

L-Theanine is an amino acid found almost exclusively in green tea that has been studied for relaxation and sleep quality effects.

• A randomized, double-blind, placebo-controlled crossover trial (Hidese et al., PMID: 31623400; n=30 healthy adults) found that L-Theanine 200 mg/day for 4 weeks was associated with improvement in PSQI scores, including sleep-latency and sleep-disturbance subscales, compared with placebo. The study was small and was not conducted in patients with diagnosed insomnia; it does not establish L-Theanine as a treatment for insomnia disorders.
• The 150 mg dose in this formula is within the range studied in clinical trials. Generally well-tolerated.

3. Ashwagandha Extract (root, 2.5% withanolides) — 150 mg [Small human RCT evidence]

Ashwagandha (Withania somnifera) is an adaptogenic herb with human trial data in sleep and stress.

• A double-blind, randomized, placebo-controlled trial (Langade et al., PMID: 31728244; n=60 adults with insomnia and anxiety) found ashwagandha root extract 300 mg twice daily for 10 weeks improved sleep onset latency, total sleep time, sleep efficiency, and next-day alertness versus placebo. The dose studied (600 mg/day total) is considerably higher than the 150 mg in this formula; whether the lower dose produces comparable benefit is not established.
• Separate human studies have reported reductions in stress measures and, in some populations, serum cortisol with certain ashwagandha extracts; whether these effects explain sleep improvements is not established.
• Pregnancy and lactation: Avoid use because of safety concerns and insufficient clinical safety data unless specifically directed by a qualified healthcare professional. Potential interactions with thyroid medications and immunosuppressants; discuss with your pharmacist.

4. Saffron Extract (flower, 3:1) — 50 mg [Preliminary but growing human RCT evidence for sleep]

Saffron (Crocus sativus) contains bioactive compounds crocin and safranal. Human RCT evidence for saffron specifically targeting sleep outcomes is growing, with several trials published since 2020.

• A randomized, double-blind, placebo-controlled trial (Lopresti et al., PMID: 32056539; n=63 adults with self-reported sleep problems) found standardized saffron extract 14 mg twice daily for 28 days was associated with improvements in insomnia severity, restorative sleep, and overall sleep quality compared with placebo. The study was small and industry funded, and the specific extract and dose differ from this formula.
• Subsequent human RCTs (including studies with 120 and 165 participants, PMIDs 34438361 and 40698027) further support describing saffron’s human sleep evidence as preliminary but growing across multiple controlled trials.
• The dose and standardization in this formula should be compared against studied preparations before assuming equivalence.

5. 5-Hydroxytryptophan (from Griffonia seed extract) — 50 mg [Limited human RCT evidence; important drug interactions]

5-HTP is the direct metabolic precursor to serotonin, which is subsequently converted to melatonin in the pineal gland. It is proposed to support the tryptophan → serotonin → melatonin pathway; the pharmacological plausibility of this mechanism is distinct from demonstrating meaningful sleep improvement from supplementation.

• A 2024 randomized controlled trial (Sutanto et al., PMID: 38309227; n=30 older adults) evaluated 5-HTP 100 mg/day for 12 weeks. Certain sleep-quality measures improved, particularly among participants classified as poor sleepers at baseline. The study was small and population-specific (older adults); larger confirmatory trials in broader populations are needed. Note: the dose studied (100 mg/day) is higher than the 50 mg in this formula.
• Important safety consideration: Because 5-HTP increases serotonin precursor availability, combining it with SSRIs, SNRIs, MAOIs, tramadol, or other serotonergic agents may increase serotonergic effects and could increase the risk of serotonin toxicity. This risk is pharmacologically based; it has not been quantified in controlled clinical trials. Patients taking serotonergic medications should not start this product without pharmacist or prescriber review.

6. Passion Flower Extract (aerial parts, 4:1) — 150 mg [Very limited human evidence]

Passion Flower (Passiflora incarnata) has been studied for anxiety and sleep. It is proposed to interact with GABA receptor systems, but the specific binding mechanisms and their relevance to human oral supplementation remain areas of active research — the pharmacology is not equivalent to benzodiazepine receptor binding in clinical terms.

• A randomized, double-blind, placebo-controlled repeated-measures trial (Ngan & Conduit, PMID: 21294203; n=41 healthy adults) found passionflower tea improved subjective sleep quality over one week versus placebo. The study used a tea preparation; dose equivalence to standardized extract is uncertain. This does not establish passionflower extract as a sleep treatment.
• Human evidence for Passion Flower as a sleep supplement is limited; most trials are small and short. Generally well-tolerated in short-term use.
• Patients taking sedative medications should discuss Passion Flower use with their pharmacist due to possible additive CNS effects.

7. Lemon Balm Extract (leaf, 5% rosmarinic acid) — 150 mg [Weakest sleep evidence in this formula]

Lemon balm (Melissa officinalis) has been studied for anxiety and sleep effects. The proposed mechanism involves rosmarinic acid inhibiting GABA transaminase, increasing available GABA; this mechanism is primarily preclinical.

• Cases et al. (PMID: 22207903) conducted a prospective open-label pilot study in 20 volunteers with mild-to-moderate anxiety and sleep disturbances. Participants received a standardized Melissa officinalis extract for 15 days, with improvements reported in anxiety and insomnia measures. Because the study lacked a placebo control and was small and short-duration, it does not establish efficacy for insomnia. The frequently cited characterization of this study as a “double-blind crossover RCT” is incorrect; it was open-label and uncontrolled.
• Generally well-tolerated in short-term trials. Long-term safety data are limited.

Proposed Mechanisms

The formula covers several proposed neurochemical pathways relevant to sleep, based on the individual ingredient literature and preclinical pharmacology:

• Serotonin-melatonin pathway: 5-HTP (serotonin precursor) + Saffron (proposed serotonin reuptake modulation) + Melatonin (direct circadian signaling)
• GABAergic signaling: Lemon Balm (proposed GABA transaminase inhibition, preclinical) + Passion Flower (proposed GABA receptor interaction, mechanism not established clinically) + L-Theanine (GABA and alpha wave effects in human studies)
• HPA axis and cortisol: Ashwagandha (cortisol reduction and stress adaptation, documented in some human trials with specific extracts)

These mechanisms are biologically plausible based on the available evidence. Whether they operate additively or synergistically in the finished combination, and at the specific doses in this formula, has not been established in human clinical trials.

Safety & Medication Considerations

• 5-HTP + serotonergic medications: Combining 5-HTP with SSRIs, SNRIs, MAOIs, tramadol, or other serotonergic agents may increase serotonergic effects and could increase the risk of serotonin toxicity. This risk is pharmacologically based; it has not been quantified in controlled clinical trials. Patients taking serotonergic medications should not start this product without pharmacist or prescriber review.
• Sedative medications: Patients taking prescription sleep aids, benzodiazepines, or other CNS depressants should consult their pharmacist before adding any botanical sleep formula due to potential additive effects.
• Ashwagandha: Avoid use in pregnancy and lactation because of safety concerns and insufficient clinical safety data. Potential interactions with thyroid medications and immunosuppressants.
• Melatonin: May cause morning drowsiness in sensitive individuals. Use caution when driving or operating machinery after use.
• Pregnancy and lactation: Several ingredients in this formula have insufficient safety data for use in pregnancy or lactation; avoid unless specifically discussed with a healthcare provider.

Who May Consider Vital Nutrients® Sleep + Recover?

• Adults with difficulty falling or staying asleep who are interested in botanical and nutritional sleep support and want to discuss the evidence with a pharmacist before starting
• Adults experiencing sleep difficulties alongside stress who are interested in discussing the preliminary evidence for botanical sleep-support ingredients
• Adults interested in a multi-ingredient sleep formula who are not taking serotonergic medications and want their medications and health conditions reviewed before use
• Shift workers or travelers with disrupted circadian rhythms (melatonin is the best-supported ingredient for this use)
• Not appropriate for patients on SSRIs, SNRIs, MAOIs, tramadol, or other serotonergic medications without pharmacist or prescriber review

Selected Key Studies

1. SYSTEMATIC REVIEW / META-ANALYSIS Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS One. 2013;8(5):e63773. PMID: 23691095.
   Meta-analysis of 19 randomized placebo-controlled trials (1,683 participants) evaluating melatonin in primary sleep disorders. Melatonin produced modest but statistically significant improvements in sleep-onset latency, total sleep time, and overall sleep quality. Outcomes varied across populations and sleep disorders.
2. HUMAN RCT Hidese S, et al. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019;11(10):2362. PMID: 31623400.
   Randomized, double-blind, placebo-controlled crossover trial (n=30 healthy adults); L-Theanine 200 mg/day for 4 weeks improved PSQI sleep-latency and sleep-disturbance subscores versus placebo. Small study, not conducted in patients with diagnosed insomnia.
3. HUMAN RCT Langade D, et al. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019;11(9):e5797. PMID: 31728244.
   Double-blind, randomized, placebo-controlled trial (n=60 adults with insomnia and anxiety); ashwagandha 300 mg twice daily (600 mg/day total) for 10 weeks improved sleep onset latency, total sleep time, sleep efficiency, and next-day alertness versus placebo. Dose studied is four times the 150 mg in this formula; dose-equivalence is not established.
4. HUMAN RCT Lopresti AL, et al. Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial. J Clin Sleep Med. 2020;16(6):937–947. PMID: 32056539.
   Randomized, double-blind, placebo-controlled trial (n=63); standardized saffron extract 14 mg twice daily for 28 days improved insomnia severity, restorative sleep, and overall sleep quality versus placebo. Small study, industry funded. Specific extract and dose differ from this formula.
5. HUMAN RCT Sutanto CN, et al. The impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial. Clin Nutr. 2024;43(3):593–602. PMID: 38309227.
   Randomized controlled trial (n=30 older adults); 5-HTP 100 mg/day for 12 weeks improved certain sleep-quality measures in poor sleepers at baseline. Small study, population-specific. Dose (100 mg/day) is double the 50 mg in this formula.
6. HUMAN RCT Ngan A, Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011;25(8):1153–1159. PMID: 21294203.
   Randomized, double-blind, placebo-controlled repeated-measures trial (n=41 healthy adults); passionflower tea improved subjective sleep quality over one week versus placebo. Tea preparation; dose equivalence to standardized extract is uncertain. Does not establish passionflower extract as a sleep treatment.
7. HUMAN STUDY Cases J, et al. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011. PMID: 22207903.
   Prospective open-label pilot study (n=20); standardized Melissa officinalis extract for 15 days, with improvements in anxiety and insomnia measures reported. Lacked a placebo control; small and short-duration. Does not establish efficacy for insomnia. This is open-label and uncontrolled — not a double-blind crossover RCT as it is sometimes characterized.

Pharmacist’s Perspective

As a PharmD, I discuss Vital Nutrients® Sleep + Recover with patients looking for a multi-ingredient botanical approach to sleep support. Melatonin has the strongest human sleep evidence of the included ingredients; the botanicals and 5-HTP each have preliminary human data with varying study quality and dose differences from what is in this formula. I present it as a reasonably designed evidence-informed sleep supplement — not as a clinically proven sleep treatment.

The most important clinical step before recommending it is always a complete medication review, because the 5-HTP content creates a meaningful pharmacological risk in patients on SSRIs, SNRIs, or MAOIs. Evidence for each ingredient should be considered separately, and efficacy of the finished seven-ingredient combination has not been established in a clinical trial. Patients taking any prescription medications or with chronic medical conditions should discuss with their pharmacist or prescriber before starting. Free PharmD consultation: (408) 622-8068.

Frequently Asked Questions

Q: Can I take Sleep + Recover with my antidepressant?
A: Not without pharmacist or prescriber review. The 5-HTP in this formula can increase serotonergic activity and may interact with SSRIs, SNRIs, and MAOIs. Please contact our pharmacy before combining these.

Q: Is this formula habit-forming?
A: None of the ingredients in this formula are controlled substances or established drugs of dependence. However, long-term safety data are limited for several botanical ingredients. Use as directed and discuss extended use with your pharmacist.

Q: How long before I might notice effects?
A: Melatonin effects on sleep onset can be noticeable within the first few doses. In clinical studies evaluating certain ashwagandha extracts, outcomes were generally assessed after several weeks of consistent use. Clinical trials of the other botanical ingredients generally ran 4–12 weeks.

Q: Can I take this during pregnancy?
A: No. Several ingredients, including ashwagandha, have insufficient safety data for use in pregnancy or lactation. Do not use without explicit discussion with your OB or healthcare provider.

Related Clinical Insights Articles

• NAD+, NMN & NR: What the Research Shows →
• CoQ10 & PQQ: What the Research Shows →

Reviewed by: Dai Tran, PharmD, MBA, B.S.  View full bio →

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist

Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience

Khang Pharmacy | 2451 S King Rd., Ste A1, San Jose, CA 95122 | (408) 622-8068 | www.khangpharmacy.com